Empowering Innovation in Biotechnology and Research
Founded in 2023, ecoZist Corp. is a Canadian biotechnology company dedicated to advancing stem cell research, regenerative medicine, and life sciences innovation. Headquartered in Markham, Ontario, we develop and manufacture specialized stem cell culture media, organoid systems, and organ-on-chip platforms designed to meet the highest standards of research and clinical applications.
Our mission is simple: to give scientists and clinicians the tools they need to make breakthrough discoveries and improve human health. By combining scientific excellence with customer-focused solutions, we deliver high-quality, customizable products that help researchers achieve reproducible, meaningful results.
At ecoZist, we:
Produce premium stem cell culture media tailored for diverse cell types and research goals.
Develop advanced organoid and organ-on-chip technologies for disease modeling, drug discovery, and personalized medicine.
Provide expert support and training so our partners can maximize the impact of our tools in their work.
We are proud to collaborate with universities, hospitals, biotech firms, and research institutions across Canada and globally. Our work supports a broad range of applications, from fundamental cell biology to the development of life-saving therapies, while promoting ethical research, reducing reliance on animal testing, and driving progress in precision medicine.
With a commitment to quality, sustainability, and innovation, ecoZist Corp. is more than a supplier, we are your partner in building a healthier future.
The board members of ecoZist Corp
By striving to meet these ISO standards, ecoZist Corp. demonstrates a commitment to quality, safety, and customer satisfaction in the development and manufacture of its diagnostic and research products.
ISO 9001
ISO 13458
ISO 15189
Our Solutions
Innovative Solutions in Cell Culture
At ecoZist Corp., we are redefining what’s possible in cell culture technology. Our specialized stem cell media and advanced culture platforms are designed to empower researchers, accelerate discoveries, and enable breakthrough therapies.
Customizable Stem Cell Culture Media
Our premium media formulations are tailored to support:
Pluripotent stem cells for regenerative medicine and developmental biology.
Specialized differentiation for targeted research in neurology, cardiology, hepatology, and more.
Xeno-free and chemically defined options to ensure safety, reproducibility, and regulatory compliance.
Every batch is produced under strict quality control to deliver consistency and reliability—helping you achieve accurate, reproducible results.
Advanced 3D Culture Systems
We go beyond traditional 2D culture with technologies that mimic the complexity of living tissues:
3D Organoid Growth Media – Supports the self-organization and long-term maintenance of functional organoids.
Organ-on-Chip Platforms – Micro-engineered systems that replicate human organ physiology for realistic disease modeling and drug testing.
Microenvironmental Culture Technologies – Scaffolds and hydrogels that recreate in vivo conditions for optimal cell growth and differentiation.
Driving Personalized Medicine
Our solutions are built to support patient-specific models, enabling researchers to:
Predict drug responses with higher accuracy.
Study complex disease mechanisms in a controlled environment.
Reduce reliance on animal testing while enhancing translational relevance.
ecoZist Corp. blends scientific expertise with innovation, delivering tools that bridge the gap between research and real-world medical applications. Whether you’re conducting fundamental research, high-throughput screening, or clinical-grade cell production, we provide the technology, support, and customization you need to succeed.
ecoZist manufactures cell culture solutions under strict cleanroom standards, ensuring consistency, reliability, and superior scientific performance.
Every batch undergoes rigorous testing and validation to guarantee sterility, performance, and compliance with international research standards.
Tailor-made media and platforms designed to fit unique research goals, experimental workflows, and clinical-grade requirements for scientists.
Continuous investment in R&D drives ecoZist to develop breakthrough cell culture technologies, advancing regenerative medicine and biotechnology.
Our expert team provides guidance, training, and technical support, empowering researchers to achieve successful, reproducible results consistently.
We prioritize ethical, sustainable practices that minimize environmental impact while advancing regenerative medicine and biotechnological research globally.
Partnering with universities, biotech companies, and healthcare organizations to accelerate breakthroughs and transform ideas into impactful therapies.
ecoZist offers personalized scientific consultation, guiding researchers in selecting optimal media, platforms, and workflows to achieve reliable results.
Synergistic Partnerships: Fostering Innovation and Growth through Collaboration
At ecoZist Corp., we believe that meaningful innovation happens when expertise and vision are shared. We work closely with universities, research institutes, biotechnology firms, and healthcare providers to accelerate advancements in stem cell research, regenerative medicine, and biotechnology.
Through these collaborations, we:
Co-develop cutting-edge products and technologies tailored to specific research goals.
Share expertise and resources to address complex scientific challenges.
Facilitate faster development cycles from proof-of-concept to market-ready solutions.
Our approach combines scientific excellence, open communication, and a shared commitment to progress. Whether advancing disease modeling, refining drug discovery platforms, or improving personalized medicine, our partnerships create a multiplier effect—driving innovation, improving patient outcomes, and shaping the future of global healthcare.
EcoZist Corp.'s Goals
Short-Term Goals:
- Set Up Laboratory and Office Space
- Secure Regulatory Approvals
- Build a Skilled Team
- Launch Initial Product Line
- Develop a Strong Online Presence
- Establish Initial Partnerships
- Secure Funding and Investment
- Conduct Market Research
Mid-Term Goals:
- Develop a Diversified Product Portfolio
- Secure Key Certifications and Accreditations
- Establish a Strong National Market Presence
- Initiate Global Market Penetration
- Build a State-of-the-Art Manufacturing Facility
- Enhance Research and Development Capabilities
- Forge Strategic Collaborations
- Promote Brand Awareness through Marketing
- Develop Training and Support Programs
- Explore Additional Revenue Streams
Long-Term Goals:
- Expand Global Market Presence
- Establish a Global Network of Representatives
- Innovate Competitive and Superior-Quality Products
- Achieve Recognition from Leading Scientific and Research Centers
- Participate in International Exhibitions and Conferences
- Host Global Workshops and Training Programs
- Vertical Integration in Production
- Invest in Advanced Research and Development Facilities
- Promote Sustainable Practices in Biotechnology
Revolutionizing Biotechnology:
At ecoZist Corp., we are redefining the boundaries of what biotechnology can achieve. By combining advanced stem cell science with innovative engineering, we create tools that empower researchers, accelerate discoveries, and open new frontiers in regenerative medicine.
Our portfolio spans specialized stem cell culture media, organoid systems, and organ-on-chip platforms—all designed to deliver precision, reproducibility, and scalability. These technologies enable scientists to model complex human biology, test new therapies, and bring life-changing treatments to patients faster and more effectively.
We are committed to ethical, sustainable, and impactful innovation. From reducing reliance on animal testing to developing patient-specific disease models, our work addresses both scientific and societal needs. With each breakthrough, we aim not only to advance research but to transform healthcare, improve quality of life, and inspire the next generation of scientific progress.
Advancing Biotechnology with Quality and Compliance
Federal Incorporation (2023)
Provincial Corporation (2023)